429 related articles for article (PubMed ID: 32774333)
1. NOD2 Deficiency Promotes Intestinal CD4+ T Lymphocyte Imbalance, Metainflammation, and Aggravates Type 2 Diabetes in Murine Model.
Carlos D; Pérez MM; Leite JA; Rocha FA; Martins LMS; Pereira CA; Fraga-Silva TFC; Pucci TA; Ramos SG; Câmara NOS; Bonato VLD; Tostes RC; Silva JS
Front Immunol; 2020; 11():1265. PubMed ID: 32774333
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model.
Pérez MM; Martins LMS; Dias MS; Pereira CA; Leite JA; Gonçalves ECS; de Almeida PZ; de Freitas EN; Tostes RC; Ramos SG; de Zoete MR; Ryffel B; Silva JS; Carlos D
Immunology; 2019 Apr; 156(4):339-355. PubMed ID: 30472727
[TBL] [Abstract][Full Text] [Related]
3. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
Amiya T; Nakamoto N; Irie J; Taniki N; Chu PS; Koda Y; Miyamoto K; Yamaguchi A; Shiba S; Morikawa R; Itoh H; Kanai T
Diabetologia; 2021 Mar; 64(3):603-617. PubMed ID: 33399911
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model.
Martins LMS; Perez MM; Pereira CA; Costa FRC; Dias MS; Tostes RC; Ramos SG; de Zoete MR; Ryffel B; Silva JS; Carlos D
Immunology; 2018 May; 154(4):624-36. PubMed ID: 29722014
[TBL] [Abstract][Full Text] [Related]
5. Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes.
Cavallari JF; Denou E; Foley KP; Khan WI; Schertzer JD
Gut Microbes; 2016; 7(1):82-9. PubMed ID: 26939856
[TBL] [Abstract][Full Text] [Related]
6. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice.
Hong CP; Park A; Yang BG; Yun CH; Kwak MJ; Lee GW; Kim JH; Jang MS; Lee EJ; Jeun EJ; You G; Kim KS; Choi Y; Park JH; Hwang D; Im SH; Kim JF; Kim YK; Seoh JY; Surh CD; Kim YM; Jang MH
Gastroenterology; 2017 Jun; 152(8):1998-2010. PubMed ID: 28246016
[TBL] [Abstract][Full Text] [Related]
7. Nod2 Deficiency Leads to a Specific and Transmissible Mucosa-associated Microbial Dysbiosis Which Is Independent of the Mucosal Barrier Defect.
Al Nabhani Z; Lepage P; Mauny P; Montcuquet N; Roy M; Le Roux K; Dussaillant M; Berrebi D; Hugot JP; Barreau F
J Crohns Colitis; 2016 Dec; 10(12):1428-1436. PubMed ID: 27147452
[TBL] [Abstract][Full Text] [Related]
8. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
Cavallari JF; Pokrajac NT; Zlitni S; Foley KP; Henriksbo BD; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E305-E314. PubMed ID: 32516028
[TBL] [Abstract][Full Text] [Related]
9. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance.
Denou E; Lolmède K; Garidou L; Pomie C; Chabo C; Lau TC; Fullerton MD; Nigro G; Zakaroff-Girard A; Luche E; Garret C; Serino M; Amar J; Courtney M; Cavallari JF; Henriksbo BD; Barra NG; Foley KP; McPhee JB; Duggan BM; O'Neill HM; Lee AJ; Sansonetti P; Ashkar AA; Khan WI; Surette MG; Bouloumié A; Steinberg GR; Burcelin R; Schertzer JD
EMBO Mol Med; 2015 Mar; 7(3):259-74. PubMed ID: 25666722
[TBL] [Abstract][Full Text] [Related]
10. Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis.
de Souza PR; Guimarães FR; Sales-Campos H; Bonfá G; Nardini V; Chica JEL; Turato WM; Silva JS; Zamboni DS; Cardoso CRB
Immunobiology; 2018 Oct; 223(10):577-585. PubMed ID: 30041769
[TBL] [Abstract][Full Text] [Related]
11. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.
Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M
Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
13. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.
Moltzau Anderson J; Lipinski S; Sommer F; Pan WH; Boulard O; Rehman A; Falk-Paulsen M; Stengel ST; Aden K; Häsler R; Bharti R; Künzel S; Baines JF; Chamaillard M; Rosenstiel P
Cell Mol Gastroenterol Hepatol; 2020; 10(2):365-389. PubMed ID: 32289499
[TBL] [Abstract][Full Text] [Related]
14. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice.
Bagarolli RA; Tobar N; Oliveira AG; Araújo TG; Carvalho BM; Rocha GZ; Vecina JF; Calisto K; Guadagnini D; Prada PO; Santos A; Saad STO; Saad MJA
J Nutr Biochem; 2017 Dec; 50():16-25. PubMed ID: 28968517
[TBL] [Abstract][Full Text] [Related]
15. Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis.
Olivier S; Pochard C; Diounou H; Castillo V; Divoux J; Alcantara J; Leclerc J; Guilmeau S; Huet C; Charifi W; Varin TV; Daniel N; Foretz M; Neunlist M; Salomon BL; Ghosh P; Marette A; Rolli-Derkinderen M; Viollet B
Mol Metab; 2021 May; 47():101183. PubMed ID: 33548500
[TBL] [Abstract][Full Text] [Related]
16. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
[TBL] [Abstract][Full Text] [Related]
17. Pistachio Consumption Alleviates Inflammation and Improves Gut Microbiota Composition in Mice Fed a High-Fat Diet.
Terzo S; Mulè F; Caldara GF; Baldassano S; Puleio R; Vitale M; Cassata G; Ferrantelli V; Amato A
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935892
[TBL] [Abstract][Full Text] [Related]
18. Role of gut microbiota in sex- and diet-dependent metabolic disorders that lead to early mortality of androgen receptor-deficient male mice.
Harada N; Hanada K; Minami Y; Kitakaze T; Ogata Y; Tokumoto H; Sato T; Kato S; Inui H; Yamaji R
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E525-E537. PubMed ID: 32017595
[TBL] [Abstract][Full Text] [Related]
19. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
20. Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans.
Liaqat I; Ali NM; Arshad N; Sajjad S; Rashid F; Hanif U; Ara C; Ulfat M; Andleeb S; Awan UF; Bibi A; Mubin M; Ali S; Tahir HM; Ul-Haq I
Braz J Biol; 2021; 83():e242818. PubMed ID: 34378656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
